EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

Stablepharma's innovative Fridge-free Vaccine Technology recognised by the European Innovation Council Grant of 2.5m euros ...

Also, regarding HyBryte (TM), in October 2024, Soligenix announced that the Hong Kong Patent Office had granted the patent entitled "Systems and Methods for Producing Synthetic Hypericin." Synthetic ...

UK-based biotechnology firm Stablepharma Ltd has been awarded ?2.5 million through the prestigious European Innovation Council (EIC) Accelerator program. The grant recognises the company's ...

The authors retract this Article (DOI: 10.1021/acsabm.3c01035) due to misusage of electron microscope images in the experiments conducted simultaneously by our research group. Figure 3E in the article ...

mRNA vaccines are a novel type of vaccine that use messenger RNA (mRNA) to induce an immune response against a specific pathogen. Unlike traditional vaccines that use weakened or inactivated viruses ...